Showing all 6 results
Azithromycin Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The coating is essential to mask the extremely bitter taste and facilitate swallowing.
Active Ingredient Strength (Standard) Standard Regimen Primary Role Azithromycin Dihydrate USP/BP 250 mg 6 Tablets (3-5 Days) Step-down Therapy / Pediatric Azithromycin Dihydrate USP/BP 500 mg 3 Tablets (3 Days) Respiratory Infections / Typhoid Azithromycin Dihydrate USP/BP 1000 mg (1 g) 1 Tablet (Single Dose) STI (Chlamydia / Gonorrhea) Excipients Q.S. Pregelatinized Starch / HPMC Disintegration / Coating Biperiden Tablets
FreeProduct Composition & Strength
We supply this product as Tablets (usually White, scored). The 2 mg strength is the global standard for titration.
Active Ingredient Strength (Standard) Primary Role Biperiden Hydrochloride USP/BP 2 mg Standard Therapeutic Dose Excipients Q.S. Lactose Monohydrate / Maize Starch Filler / Binder Carbamazepine Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated or Film Coated Tablets (White, scored). We also offer Controlled Release (CR) variants upon request.
Active Ingredient Strength (Standard) Primary Role Carbamazepine USP/BP 100 mg Pediatric / Initiation Dose Carbamazepine USP/BP 200 mg Standard Adult Dose Carbamazepine USP/BP 400 mg High Dose / CR Formulation Excipients Q.S. Microcrystalline Cellulose / Sodium Starch Glycolate Carbidopa and Levodopa Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (often scored/mottled). The ratios are designed to minimize nausea while maximizing brain dopamine levels.
Carbidopa (Anhydrous) Levodopa Ratio Primary Role 10 mg 100 mg 1:10 Low Dose Initiation 25 mg 100 mg 1:4 Standard Maintenance (Best Nausea Control) 25 mg 250 mg 1:10 High Dose / Advanced Disease Excipients Q.S. Microcrystalline Cellulose / Starch / Dye Filler / Colorant Citicoline Tablets
FreeProduct Composition & Strength
We supply this product as Controlled Release (CR) Tablets (Film Coated). The matrix formulation is critical to extend the biological half-life.
Active Ingredient Strength Release Profile Primary Indication Citicoline Sodium USP/IP 500 mg Controlled Release Mild Cognitive Impairment / Maintenance Citicoline Sodium USP/IP 1000 mg Controlled Release Acute Stroke Recovery / Severe Dementia Excipients Q.S. HPMC (Release Retardant) / Magnesium Stearate Matrix System Phenytoin Tablets
FreePhenytoin Sodium tablets IP
Each Sugarcoated tablet contains :
Phenytoin Sodium IP 100 mgPhenytoin Sodium Tablets IP 100 mg
Each Filmcoated Tablets Contains:
Phenytoin Sodium IP 100 mgPhenytoin Tablets BP
Each Sugar Coated tablet contains :
Phenytoin Sodium 25 mgPhenytoin Sodium Tablets BP
Each Sugar Coated tablet contains :
Phenytoin Sodium BP 100 mgUsage: – Treat epilepsy
Category: – Anti Hypertensive / Cardiac Drugs
Therapeutic category: – Anticonvulsant, Antiepileptic
